H. B. Fuller Company (NYSE:FUL) Receives $65.50 Average PT from Brokerages

Shares of H. B. Fuller Company (NYSE:FUL) have received a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, three have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $65.50.

A number of research firms have recently weighed in on FUL. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of H. B. Fuller in a report on Friday, January 16th. Wall Street Zen raised H. B. Fuller from a “hold” rating to a “buy” rating in a report on Sunday, March 29th. Vertical Research raised H. B. Fuller from a “hold” rating to a “strong-buy” rating in a report on Friday, March 27th. UBS Group cut their price target on H. B. Fuller from $66.00 to $63.00 and set a “neutral” rating on the stock in a report on Friday, March 27th. Finally, Citigroup lifted their price target on H. B. Fuller from $67.00 to $70.00 and gave the company a “buy” rating in a report on Monday, March 30th.

H. B. Fuller Stock Performance

FUL opened at $60.38 on Thursday. The business’s 50 day moving average is $59.88 and its 200-day moving average is $60.49. The stock has a market cap of $3.29 billion, a PE ratio of 19.93, a price-to-earnings-growth ratio of 0.81 and a beta of 0.95. The company has a current ratio of 1.92, a quick ratio of 1.15 and a debt-to-equity ratio of 1.01. H. B. Fuller has a twelve month low of $48.71 and a twelve month high of $68.63.

H. B. Fuller (NYSE:FUL) last released its quarterly earnings results on Thursday, March 26th. The specialty chemicals company reported $0.57 earnings per share for the quarter, beating analysts’ consensus estimates of $0.56 by $0.01. The company had revenue of $770.84 million for the quarter, compared to analysts’ expectations of $787.77 million. H. B. Fuller had a return on equity of 11.84% and a net margin of 4.62%.The business’s revenue for the quarter was down 2.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.54 earnings per share. On average, analysts predict that H. B. Fuller will post 4.77 earnings per share for the current year.

H. B. Fuller Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 14th. Investors of record on Thursday, April 30th will be issued a dividend of $0.245 per share. The ex-dividend date of this dividend is Thursday, April 30th. This is a positive change from H. B. Fuller’s previous quarterly dividend of $0.24. This represents a $0.98 annualized dividend and a yield of 1.6%. H. B. Fuller’s dividend payout ratio is presently 32.34%.

Insider Buying and Selling

In other news, CEO Celeste Beeks Mastin bought 5,170 shares of the company’s stock in a transaction that occurred on Tuesday, April 7th. The shares were purchased at an average price of $57.08 per share, with a total value of $295,103.60. Following the completion of the acquisition, the chief executive officer directly owned 8,670 shares in the company, valued at approximately $494,883.60. This trade represents a 147.71% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.83% of the stock is currently owned by insiders.

Institutional Investors Weigh In On H. B. Fuller

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Bleakley Financial Group LLC raised its holdings in H. B. Fuller by 1.5% during the fourth quarter. Bleakley Financial Group LLC now owns 11,687 shares of the specialty chemicals company’s stock worth $695,000 after purchasing an additional 168 shares in the last quarter. California State Teachers Retirement System raised its holdings in H. B. Fuller by 0.3% during the second quarter. California State Teachers Retirement System now owns 50,486 shares of the specialty chemicals company’s stock worth $3,037,000 after purchasing an additional 173 shares in the last quarter. Glenmede Investment Management LP raised its holdings in H. B. Fuller by 3.9% during the third quarter. Glenmede Investment Management LP now owns 4,809 shares of the specialty chemicals company’s stock worth $285,000 after purchasing an additional 179 shares in the last quarter. CIBC Asset Management Inc raised its holdings in H. B. Fuller by 3.6% during the fourth quarter. CIBC Asset Management Inc now owns 5,273 shares of the specialty chemicals company’s stock worth $314,000 after purchasing an additional 185 shares in the last quarter. Finally, Allworth Financial LP raised its holdings in H. B. Fuller by 50.1% during the fourth quarter. Allworth Financial LP now owns 578 shares of the specialty chemicals company’s stock worth $34,000 after purchasing an additional 193 shares in the last quarter. Institutional investors own 95.93% of the company’s stock.

About H. B. Fuller

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.